Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

por Montes, Marisa, Nelson, Mark, Marie Girard, Pierre, Sasadeusz, Joe, Horban, Andrzej, Grinsztejn, Beatriz, Zakharova, Natalia, Rivero, Antonio, Lathouwers, Erkki, Janssen, Katrien, Ouwerkerk-Mahadevan, Sivi, Witek, James
Publicado 2014

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years

por Gazzard, Brian, Marie Girard, Pierre, Di Perri, Giovanni, Gallant, Joel, Towner, William, Rogatto, Felipe, Demorin, Jennifer, McColl, Damian, Liu, Hui, Rhee, Martin, Szwarcberg, Javier, Piontkowsky, David
Publicado 2014